clopidogrel taw pharma (previously clopidogrel mylan)
taw pharma (ireland) limited - hydrochlorid klopidogrelu - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotické činidla - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:, - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). , - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.
imatinib teva pharma 400mg potahovaná tableta
teva pharma b.v., haarlem array - 16298 imatinib-mesilÁt - potahovaná tableta - 400mg - imatinib
methoxsalen maco pharma 20mcg/ml roztok pro úpravu krevní frakce
maco pharma, mouvaux array - 1787 methoxsalen - roztok pro úpravu krevní frakce - 20mcg/ml - jinÁ imunostimulancia
rapibloc 20mg/2ml koncentrát pro injekční roztok
amomed pharma gmbh, vídeň array - 19125 landiolol-hydrochlorid - koncentrát pro injekční roztok - 20mg/2ml - landiolol
rapibloc 300mg prášek pro infuzní roztok
amomed pharma gmbh, vídeň array - 19125 landiolol-hydrochlorid - prášek pro infuzní roztok - 300mg - landiolol
rosuvastatin tad 10mg potahovaná tableta
tad pharma gmbh, cuxhaven array - 16812 vÁpenatÁ sŮl rosuvastatinu - potahovaná tableta - 10mg - rosuvastatin
rosuvastatin tad 20mg potahovaná tableta
tad pharma gmbh, cuxhaven array - 16812 vÁpenatÁ sŮl rosuvastatinu - potahovaná tableta - 20mg - rosuvastatin
rosuvastatin tad 30mg potahovaná tableta
tad pharma gmbh, cuxhaven array - 16812 vÁpenatÁ sŮl rosuvastatinu - potahovaná tableta - 30mg - rosuvastatin
rosuvastatin tad 40mg potahovaná tableta
tad pharma gmbh, cuxhaven array - 16812 vÁpenatÁ sŮl rosuvastatinu - potahovaná tableta - 40mg - rosuvastatin
rosuvastatin tad 5mg potahovaná tableta
tad pharma gmbh, cuxhaven array - 16812 vÁpenatÁ sŮl rosuvastatinu - potahovaná tableta - 5mg - rosuvastatin